Speeding up Alzheimer’s research: Progerin turbocharges cellular models for quicker drug screening

The study reveals that introducing progerin, a protein associated with accelerated aging, into cellular models of Alzheimer’s Disease (AD) can hasten the development of AD-related traits. This innovative approach offers a more efficient method for studying AD mechanisms, potentially accelerating the discovery of new treatments.

HHS selects intranasal vaccine candidates for Project NextGen, doles out $500M in funds

HHS on Friday announced its selections for the next-generation of Covid-19 vaccine candidates to receive $500 million in funding as part of the government’s Project

October 14, 2023

Absci, PrecisionLife Partner to Develop AI-Enabled Drug Pipeline

What You Should Know: – Absci, a generative AI drug creation company, and PrecisionLife, a pioneer in computational biology for complex chronic diseases, have announced

December 20, 2023

New insights into how and when bipedal locomotion evolved in human ancestors

One of the most fascinating periods in the evolution of the human lineage is the appearance of the first ancestors capable of bipedalism.

November 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.